Itau Unibanco Holding S.A.
BMRN icon

Itau Unibanco Holding S.A.’s BioMarin Pharmaceuticals BMRN Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-647
Closed -$35K – 360
2025
Q3 		$35K Hold
647
– – ﹤0.01% 287
2025
Q2 		$35.6K Sell
647
-11
-2% -$648 ﹤0.01% 296
2025
Q1 		$47K Sell
658
-5
-0.8% -$336 ﹤0.01% 269
2024
Q4 		$43.6K Buy
663
+90
+16% +$6.03K ﹤0.01% 260
2024
Q3 		$40.3K Buy
573
+4
+0.7% +$334 ﹤0.01% 201
2024
Q2 		$46.8K Buy
+569
New +$47.4K ﹤0.01% 179
2024
Q1 		– Sell
-667
Closed -$64.3K – 160
2023
Q4 		$64.3K Buy
667
+79
+13% +$6.99K ﹤0.01% 207
2023
Q3 		$52K Sell
588
-3
-0.5% -$267 ﹤0.01% 272
2023
Q2 		$51.2K Sell
591
-2
-0.3% -$188 ﹤0.01% 331
2023
Q1 		$57.7K Sell
593
-2
-0.3% -$207 ﹤0.01% 337
2022
Q4 		$61.6K Buy
595
+23
+4% +$2.16K ﹤0.01% 331
2022
Q3 		$48K Sell
572
-297
-34% -$26.4K ﹤0.01% 391
2022
Q2 		$72K Hold
869
– – ﹤0.01% 310
2022
Q1 		$67K Hold
869
– – ﹤0.01% 292
2021
Q4 		$77K Buy
869
+236
+37% +$19.5K ﹤0.01% 247
2021
Q3 		$49K Buy
633
+225
+55% +$17.8K ﹤0.01% 266
2021
Q2 		$34K Buy
+408
New +$32.3K ﹤0.01% 248

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Itau Unibanco Holding S.A.'s BMRN Position: Q4 2025 in Review

Itau Unibanco Holding S.A. sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2025, closing a stake of 647 shares — an estimated $35K sold.

Itau Unibanco Holding S.A. first reported a position in BMRN in Q2 2021 and held it in 17 quarters. The position peaked at $77K in Q4 2021. 540 funds tracked by Wall St. Rank hold BMRN as of Q4 2025.

  • Itau Unibanco Holding S.A. reported no remaining BioMarin Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 647 BioMarin Pharmaceuticals shares in Q4 2025, an estimated $35K.
  • Itau Unibanco Holding S.A. first reported a position in BioMarin Pharmaceuticals in Q2 2021 and held it in 17 quarters.
  • Itau Unibanco Holding S.A.'s BioMarin Pharmaceuticals position peaked at $77K in Q4 2021.
  • 540 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2025.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2025, filed 13 Feb 2026.